Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down 0.10% Nasdaq Up 0.23%
Streaming
Ticker Tape: On

More On TBGNF

Quotes

Charts

News & Info

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates
  • Research Reports

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

ThromboGenics NV (TBGNF)

-Other OTC
30.65 Down 0.55(1.76%) 12:38PM EDT
Get the big picture on all your investments.
Prev Close:31.20
Open:30.85
Bid:N/A
Ask:N/A
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:30.65 - 30.85
52wk Range:22.70 - 51.25
Volume:1,124
Avg Vol (3m):1,152
Market Cap:1.11B
P/E (ttm):33.35
EPS (ttm):0.92
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Reports

  • No Reports available for TBGNF at this time.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):7.71
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ThromboGenics NV, an integrated biopharmaceutical company, is engaged in developing and commercializing ophthalmic and oncology medicines in Belgium and interntionally. View More

Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback